Multivariate analysis of human immunodeficiency virus type 1 neutralization data
about
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodiesAdditive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6International network for comparison of HIV neutralization assays: the NeutNet report IIInternational network for comparison of HIV neutralization assays: the NeutNet report.W-curve alignments for HIV-1 genomic comparisonsA human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolatesBiologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines.Extent of antigenic diversity in the V3 region of the surface glycoprotein, gp120, of human immunodeficiency virus type 1 group M and consequences for serotypingNeutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage.Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1.Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes.Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees.Neutralization patterns and evolution of sequential HIV type 1 envelope sequences in HIV type 1 subtype B-infected drug-naive individuals.Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus.Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa.Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors.Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant.Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins.Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein.Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIVAutologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals.Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective Outcome.
P2860
Q24531479-8F8AB810-274C-4B80-A912-E99AA298BBD2Q24561905-87AF36F8-06FF-465E-B174-E6300ECCC9FDQ27469855-206244E9-B221-4F73-93C0-5BC3C2B10B8DQ28730045-E7922FDD-4468-4019-930B-2A65DE0A43D1Q33410826-26CB51FF-4AB1-4C64-94BA-147B849369EDQ33598708-3CF235B1-C781-4A0B-9A7F-ED75474B9012Q33603494-5715067F-E26B-49FD-A5B6-48C8C45CBA79Q33780524-C65CDA29-F6CB-4B79-A687-3B5068343CD5Q33782134-6EB23374-CC5A-4A62-A725-E260DAF1BF78Q33783714-4A349A05-6657-4A21-B29A-1EE2C2A7062BQ33785510-1D2674E6-A442-46A0-822C-03AF088A03DBQ33787329-D99BE7EA-6AAB-4E05-AA50-8B701C3F48FFQ33809112-540E76A1-3F65-4708-BBE8-15AD8ADDC3F3Q33842152-50FF6052-75D0-408B-8303-C71D12954240Q34069214-335062F8-7D4D-4FA1-B8B5-9290B58EDF2AQ34085098-3010F47F-6251-48D4-952C-0339488ABBBBQ34312037-185926DC-B458-468F-B8BD-BCC36FFA7A61Q34332009-26328F01-F9E3-4C96-BC3C-7B1AA4916E71Q34593647-77DA5576-EAC9-40B3-ADAB-3EB4FAF9EEE5Q35857221-0E867DB2-6AA8-483A-9178-228255E3632CQ35879339-6BD437AE-8100-4B7C-B4C5-CF05C8F8AA3EQ36475897-454C9E50-8917-4B49-B6A6-B2DCAEA66E78Q36994644-49F08AF5-C671-4448-A558-20EBA585D14EQ37742876-31D7CE2D-BE94-44F7-B3DB-8D3DBC063B86Q39550518-694D3263-545A-4EB6-81C4-508A6F7F159EQ39879382-4B7F3942-B359-4EC0-90A6-061930D6A3A5Q47218587-A9F9AF15-C8AA-419D-9CA0-239297DD14E3
P2860
Multivariate analysis of human immunodeficiency virus type 1 neutralization data
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Multivariate analysis of human immunodeficiency virus type 1 neutralization data
@ast
Multivariate analysis of human immunodeficiency virus type 1 neutralization data
@en
type
label
Multivariate analysis of human immunodeficiency virus type 1 neutralization data
@ast
Multivariate analysis of human immunodeficiency virus type 1 neutralization data
@en
prefLabel
Multivariate analysis of human immunodeficiency virus type 1 neutralization data
@ast
Multivariate analysis of human immunodeficiency virus type 1 neutralization data
@en
P2093
P2860
P1433
P1476
Multivariate analysis of human immunodeficiency virus type 1 neutralization data
@en
P2093
Heyndrickx L
Janssens W
Nkengasong J
van der Groen G
P2860
P304
P407
P50
P577
1996-09-01T00:00:00Z